Emile Nuwaysir
Director
Business Development
inVeritas
United States of America
Biography
Dr. Nuwaysir is currently the President and CEO of BlueRock Therapeutics, a company founded by Versant Ventures and Bayer AG. Prior to BlueRock, he was the President of a regenerative medicine division of Fujifilm (Cellular Dynamics International, Inc. – a Fujifilm Company) and President of Opsis Therapeutics, a biotech developing cell therapies for the retina. Prior to that, he was Chief Operating Officer of Cellular Dynamics International (CDI) where he helped manage growth from pre-revenue startup to a public company traded on NASDAQ, through the S1 SEC filing, IPO roadshow, public company management and the ultimate acquisition by FujiFilm for $307M. Prior to CDI, he was the SVP of Program Management and Chief Technical Officer at Roche NimbleGen, a division of Roche Diagnostics, where he oversaw product portfolio and lifecycle management, managed all Business Development activities and all R&D activities.
Research Interest
Business and Development
